Erythropoietin biosimilar (Chalver Laboratorios)
促红细胞生成素生物类似药（Chalver Laboratorios）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameErythropoietin biosimilar (Chalver Laboratorios)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2012/10/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChalver Laboratorios
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A